CD200 and non-small cell lung carcinoma: CD200 is overexpressed in 29.7% of non-small-cell lung cancer (NSCLC) patients and 33.3% of patients with lung large-cell neuroendocrine carcinoma (LCNEC), exhibiting a moderate correlation with PD-L1 expression [111].